
PROK
Healthcare · Biotechnology · $417.2M market cap
$1.04-0.10 (-9.1%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -30.4% over 90 days · 30-day revisions 3 up, 2 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | After the close | -0.13 | -0.17 | -30.8% |
| Aug 10, 2026 | After the close | -0.13 | -0.15 | -15.4% |
| May 15, 2026 | Time not confirmed | -0.14 | -0.14 | -1.8% |
| Mar 18, 2026 | After the close | -0.15 | -0.14 | +6.7% |
| Nov 10, 2025 | After the close | -0.14 | -0.12 | +14.3% |
| Aug 12, 2025 | After the close | -0.14 | -0.13 | +7.1% |
| May 12, 2025 | Time not confirmed | -0.16 | -0.13 | +18.8% |
| Mar 17, 2025 | Before the open | -0.15 | -0.17 | -13.3% |
| Nov 12, 2024 | Before the open | -0.22 | -0.14 | +36.4% |
| Aug 9, 2024 | Before the open | -0.18 | -0.16 | +11.1% |
| May 10, 2024 | After the close | -0.18 | -0.16 | +11.1% |
| Mar 22, 2024 | Before the open | -0.17 | -0.09 | +47.1% |
| Nov 14, 2023 | After the close | -0.14 |
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of…
| -0.18 |
| -28.6% |
| Aug 10, 2023 | After the close | -0.41 | -0.14 | +65.9% |
| May 11, 2023 | After the close | -0.12 | -0.16 | -33.3% |
| Mar 28, 2023 | After the close | -0.24 | -0.11 | +54.2% |
| Nov 14, 2022 | Before the open | -0.31 | -0.13 | +58.1% |
| Aug 12, 2022 | After the close | -0.06 | -0.06 | +7.0% |
| May 16, 2022 | After the close | — | -0.12 | — |
| Mar 24, 2022 | After the close | — | -0.06 | — |
| Nov 15, 2021 | Time not confirmed | — | -0.01 | — |
| Aug 16, 2021 | Time not confirmed | — | -0.01 | — |
| Jun 9, 2021 | Time not confirmed | — | 0.00 | — |